These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22517692)

  • 41. Influence of frozen-section analysis of sentinel lymph node and lumpectomy margin status on reoperation rates in patients undergoing breast-conservation therapy.
    McLaughlin SA; Ochoa-Frongia LM; Patil SM; Cody HS; Sclafani LM
    J Am Coll Surg; 2008 Jan; 206(1):76-82. PubMed ID: 18155571
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Histopathologic analysis of sentinel lymph nodes in breast carcinoma.
    Hsieh PP; Ho WL; Yeh DC; Liu TJ; Wu CC; Lin JH; Wang SJ
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):744-50. PubMed ID: 11076431
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy.
    Alran S; De Rycke Y; Fourchotte V; Charitansky H; Laki F; Falcou MC; Benamor M; Freneaux P; Salmon RJ; ; Sigal-Zafrani B
    Ann Surg Oncol; 2007 Aug; 14(8):2195-201. PubMed ID: 17294071
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A positive intramammary lymph node does not mandate a complete axillary node dissection.
    Diaz R; Degnim AC; Boughey JC; Nassar A; Jakub JW
    Am J Surg; 2012 Feb; 203(2):151-5. PubMed ID: 21788008
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node biopsy or containing micrometastases and without further lymphadenectomy: a monocentric review of 8 years and 481 cases.
    Toussaint A; Nogaret JM; Veys I; Hertens D; Noterman D; De Neubourg F; Larsimont D; Bourgeois P
    Breast J; 2011; 17(4):337-42. PubMed ID: 21752137
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ratio of positive to total number of sentinel nodes predicts nonsentinel node status in breast cancer patients.
    Tan YY; Fan YG; Lu Y; Hwang S; Ewing C; Esserman L; Morita E; Treseler P; Leong SP
    Breast J; 2005; 11(4):248-53. PubMed ID: 15982390
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Axillary lymph node dissection can be avoided in women with breast cancer with intraoperative, false-negative sentinel lymph node biopsies.
    Takei H; Kurosumi M; Yoshida T; Ishikawa Y; Hayashi Y; Ninomiya J; Tozuka K; Oba H; Inoue K; Nagai S; Saito Y; Kazumoto T; Saitoh J; Tabei T
    Breast Cancer; 2010; 17(1):9-16. PubMed ID: 19701679
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intraoperative cytologic examination of breast sentinel lymph nodes: test utility and patient impact.
    Dabbs DJ; Fung M; Johnson R
    Breast J; 2004; 10(3):190-4. PubMed ID: 15125743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer.
    Ozmen V; Karanlik H; Cabioglu N; Igci A; Kecer M; Asoglu O; Tuzlali S; Mudun A
    Breast Cancer Res Treat; 2006 Jan; 95(1):1-6. PubMed ID: 16322900
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Axillary recurrence after negative sentinel lymph node biopsy without axillary dissection: a study on 479 breast cancer patients.
    Zavagno G; Carcoforo P; Franchini Z; Renier M; Barutta L; De Salvo GL; Maravegias K; Capitanio G; Nitti D; Lise M
    Eur J Surg Oncol; 2005 Sep; 31(7):715-20. PubMed ID: 16005176
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Sentinel lymph node biopsy in breast cancer].
    Shen K; Nirmal L; Han Q; Wu J; Lu J; Zhang J; Liu G; Shao Z; Shen Z
    Zhonghua Wai Ke Za Zhi; 2002 May; 40(5):347-50. PubMed ID: 12133338
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic role of micrometastases in sentinel lymph node in patients with invasive breast cancer.
    Rovera F; Fachinetti A; Rausei S; Chiappa C; Lavazza M; Arlant V; Marelli M; Boni L; Dionigi G; Dionigi R
    Int J Surg; 2013; 11 Suppl 1():S73-8. PubMed ID: 24380559
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contemporary Axillary Management in cT1-2N0 Breast Cancer with One or Two Positive Sentinel Lymph Nodes: Factors Associated with Completion Axillary Lymph Node Dissection Within the National Cancer Database.
    Stafford AP; Hoskin TL; Day CN; Sanders SB; Boughey JC
    Ann Surg Oncol; 2022 Aug; 29(8):4740-4749. PubMed ID: 35451727
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors that determine whether a patient receives completion axillary lymph node dissection after a positive sentinel lymph node biopsy for breast cancer in British Columbia.
    Aslani N; Swanson T; Kennecke H; Woods R; Davis N
    Can J Surg; 2011 Aug; 54(4):237-42. PubMed ID: 21651836
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognosis and treatment of micrometastatic breast cancer sentinel lymph node: a population-based study.
    Cortesi L; Proietto M; Cirilli C; Tazzioli G; Andreotti A; Federico M
    J Surg Oncol; 2012 Sep; 106(4):399-405. PubMed ID: 22488263
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Overview of the pathological results and treatment characteristics in the first 1000 patients randomized in the SERC trial: axillary dissection versus no axillary dissection in patients with involved sentinel node.
    Houvenaeghel G; Cohen M; Raro P; De Troyer J; de Lara CT; Gimbergues P; Gauthier T; Faure-Virelizier C; Vaini-Cowen V; Lantheaume S; Regis C; Darai E; Ceccato V; D'Halluin G; Del Piano F; Villet R; Jouve E; Beedassy B; Theret P; Gabelle P; Zinzindohoue C; Opinel P; Marsollier-Ferrer C; Dhainaut-Speyer C; Colombo PE; Lambaudie E; Tallet A; Boher JM;
    BMC Cancer; 2018 Nov; 18(1):1153. PubMed ID: 30463611
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management and results of treatment of breast cancer patients having sentinel lymph node micrometastases.
    Nowikiewicz T; Srutek E; Jankowski M; Las-Jankowska M; Klag M; Kozak D; Glowacka I; Zegarski W
    Neoplasma; 2014; 61(3):299-304. PubMed ID: 24824931
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Women Could Avoid Axillary Lymph Node Dissection by Choosing Breast-Conserving Therapy Instead of Mastectomy.
    Vane MLG; Hunter-Squires J; Kim S; Smidt ML; Giuliano AE
    Ann Surg Oncol; 2021 May; 28(5):2522-2528. PubMed ID: 33586070
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011.
    Olson JA; McCall LM; Beitsch P; Whitworth PW; Reintgen DS; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Giuliano AE;
    J Clin Oncol; 2008 Jul; 26(21):3530-5. PubMed ID: 18640934
    [TBL] [Abstract][Full Text] [Related]  

  • 60. De-implementation of Axillary Dissection in Women Undergoing Mastectomy for Breast Cancer.
    Leonard LD; de Araujo TB; Quinn C; Thomas MB; Beaty L; Mott NM; Colborn K; Heelan AA; Tevis SEA; Christian N; Arhendt G; Gleisner AL
    Ann Surg Oncol; 2023 Sep; 30(9):5692-5702. PubMed ID: 37326811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.